Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 541

1.

Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.

Murrell W, Wetzig A, Donnellan M, Féron F, Burne T, Meedeniya A, Kesby J, Bianco J, Perry C, Silburn P, Mackay-Sim A.

Stem Cells. 2008 Aug;26(8):2183-92. doi: 10.1634/stemcells.2008-0074. Epub 2008 Jun 5.

2.

Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.

Levy YS, Bahat-Stroomza M, Barzilay R, Burshtein A, Bulvik S, Barhum Y, Panet H, Melamed E, Offen D.

Cytotherapy. 2008;10(4):340-52. doi: 10.1080/14653240802021330.

PMID:
18574767
3.

Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats.

Ben-Hur T, Idelson M, Khaner H, Pera M, Reinhartz E, Itzik A, Reubinoff BE.

Stem Cells. 2004;22(7):1246-55.

4.

Embryonic and adult stem cells as a source for cell therapy in Parkinson's disease.

Levy YS, Stroomza M, Melamed E, Offen D.

J Mol Neurosci. 2004;24(3):353-86. Review.

PMID:
15655260
5.

Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

Kim JH, Auerbach JM, Rodríguez-Gómez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sánchez-Pernaute R, Bankiewicz K, McKay R.

Nature. 2002 Jul 4;418(6893):50-6. Epub 2002 Jun 20.

PMID:
12077607
6.

Stem cell-based therapy for Parkinson's disease.

Correia AS, Anisimov SV, Li JY, Brundin P.

Ann Med. 2005;37(7):487-98. Review.

PMID:
16278162
7.

Induction of A9 dopaminergic neurons from neural stem cells improves motor function in an animal model of Parkinson's disease.

O'Keeffe FE, Scott SA, Tyers P, O'Keeffe GW, Dalley JW, Zufferey R, Caldwell MA.

Brain. 2008 Mar;131(Pt 3):630-41. doi: 10.1093/brain/awm340. Epub 2008 Jan 17.

PMID:
18202103
8.

Stem cell therapy for Parkinson's disease.

Takahashi J.

Ernst Schering Res Found Workshop. 2006;(60):229-44. Review.

PMID:
16903426
9.

Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior.

Park S, Kim E, Koh SE, Maeng S, Lee WD, Lim J, Shim I, Lee YJ.

Brain Res. 2012 Jul 23;1466:158-66. doi: 10.1016/j.brainres.2012.05.032. Epub 2012 May 24.

PMID:
22634376
10.

Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease?

Arias-Carrión O, Yuan TF.

Med Hypotheses. 2009 Nov;73(5):757-9. doi: 10.1016/j.mehy.2009.04.029. Epub 2009 May 24.

PMID:
19467573
11.

Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease.

Parish CL, Parisi S, Persico MG, Arenas E, Minchiotti G.

Stem Cells. 2005 Apr;23(4):471-6.

12.

Models of repair mechanisms for future treatment modalities of Parkinson's disease.

Isacson O.

Brain Res Bull. 2002 Apr;57(6):839-46. Review.

PMID:
12031282
13.

Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease.

Li M, Zhang SZ, Guo YW, Cai YQ, Yan ZJ, Zou Z, Jiang XD, Ke YQ, He XY, Jin ZL, Lu GH, Su DQ.

Neurochem Res. 2010 Oct;35(10):1522-9. doi: 10.1007/s11064-010-0211-6. Epub 2010 Jul 24.

PMID:
20658188
14.

Neurorestoration in Parkinson's disease by cell replacement and endogenous regeneration.

Hermann A, Gerlach M, Schwarz J, Storch A.

Expert Opin Biol Ther. 2004 Feb;4(2):131-43. Review.

PMID:
14998773
15.

Stem cells in the treatment of Parkinson's disease.

Arenas E.

Brain Res Bull. 2002 Apr;57(6):795-808. Review.

PMID:
12031276
16.

Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.

Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, Maki M, Kim SU, Borlongan CV.

J Neurosci. 2006 Nov 29;26(48):12497-511.

17.

Pattern of long-term sensorimotor recovery following intrastriatal and--accumbens DA micrografts in a rat model of Parkinson's disease.

Falkenstein G, Rosenthal C, Reum T, Morgenstern R, Döbrössy M, Nikkhah G.

J Comp Neurol. 2009 Jul 1;515(1):41-55. doi: 10.1002/cne.22035.

PMID:
19399892
18.

Production of dopaminergic neurons for cell therapy in the treatment of Parkinson's disease.

Peaire AE, Takeshima T, Johnston JM, Isoe K, Nakashima K, Commissiong JW.

J Neurosci Methods. 2003 Mar 30;124(1):61-74.

PMID:
12648765
19.

[Neuromodulation for Parkinson's disease].

Takahashi J.

Rinsho Shinkeigaku. 2008 Apr;48(4):233-41. Review. Japanese.

PMID:
18453154
20.

A multiple target neural transplantation strategy for Parkinson's disease.

Ramachandran AC, Bartlett LE, Mendez IM.

Rev Neurosci. 2002;13(3):243-56. Review.

PMID:
12405227

Supplemental Content

Support Center